SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007068
Filing Date
2024-05-07
Accepted
2024-05-07 16:25:53
Documents
72
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q armp-20240331x10q.htm   iXBRL 10-Q 1068906
2 EX-31.1 armp-20240331xex31d1.htm EX-31.1 15785
3 EX-31.2 armp-20240331xex31d2.htm EX-31.2 15283
4 EX-32.1 armp-20240331xex32d1.htm EX-32.1 8030
5 EX-32.2 armp-20240331xex32d2.htm EX-32.2 8213
6 GRAPHIC armp-20240331x10q001.jpg GRAPHIC 44620
  Complete submission text file 0001558370-24-007068.txt   5224912

Data Files

Seq Description Document Type Size
7 EX-101.SCH armp-20240331.xsd EX-101.SCH 43018
8 EX-101.CAL armp-20240331_cal.xml EX-101.CAL 47751
9 EX-101.DEF armp-20240331_def.xml EX-101.DEF 144733
10 EX-101.LAB armp-20240331_lab.xml EX-101.LAB 364248
11 EX-101.PRE armp-20240331_pre.xml EX-101.PRE 274252
76 EXTRACTED XBRL INSTANCE DOCUMENT armp-20240331x10q_htm.xml XML 747498
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37544 | Film No.: 24922397
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)